Charming Medical Limited (MCTA) Stock Price & Analysis

Charming Medical Limited (MCTA) closed at USD 29.36 on Wednesday, October 14, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 29.36; the Oct 14, 2026 session ranged USD 29.36–29.36 on volume of 0 shares. Market capitalization is $445.55M, with a 52-week range of USD 4.3–31.7 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:58 UTC.

Also available as compact Markdown for AI agents: nexqual.com/MCTA.md

Key facts (MCTA)

Analysts (MCTA)

Consensus None.

Total return (dividends reinvested) (MCTA)

1Y (from 2025-10-21)5Y (from 2025-10-20)
Total return+319.4%+296.1%
S&P 500 (SPY)+18.1%+85.1%
Per year+329.9%+304.7%
Volatility (annualized)76.1%118.6%
Max drawdown-25.6% (Oct 2025→Nov 2025)-6.0% (Oct 2025→Nov 2025)

Key Statistics (as of October 16, 2026 at 05:58 UTC)

PriceUSD 29.36
Change▲ 0.00% (up)
Previous CloseUSD 29.36
OpenUSD 0
Day RangeUSD 29.36 – 29.36
52-Week RangeUSD 4.3 – 31.7
Volume0 shares
Market Cap$445.55M
ExchangeNCM

Technical Analysis (MCTA)

Nexqual's technical model rates MCTA "STRONG SELL" based on 0 bullish and 6 bearish signals across 127 daily candles, as of October 16, 2026 at 05:58 UTC.

Overall SignalSTRONG SELL
RSI (14)100 (overbought)
vs SMA50Below (USD 29.36)
MACD0 (negative)

Analyst Ratings (MCTA)

Wall Street analysts rate MCTA "None", per Nexqual as of October 16, 2026 at 05:58 UTC.

Consensus RatingNone

Earnings (MCTA)

Source: Nexqual, October 16, 2026 at 05:58 UTC.

Financials & Fundamentals (MCTA)

Total Revenue$4.81M
Revenue Growth (latest quarter, YoY)-18.90%
Gross Margin+96.36%
Operating Margin+4.86%
Profit Margin-0.47%
ROE-0.87%
Debt / Equity0.18
Current Ratio1.89
Total Cash$7.68M
Total Debt$908,016

Source: Nexqual, October 16, 2026 at 05:58 UTC.

Financial Health Score (MCTA)

Nexqual rates Charming Medical Limited's overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:58 UTC.

GrowthCritical — Revenue -19% YoY (latest Q), sharp decline
ProfitabilityWeak — Pre-revenue or very early stage
Balance SheetStrong — $8M cash, no debt
Cash FlowWeak — Operating cash flow -$1M (TTM)
EfficiencyCritical — ROE -1%, ROA 0.9%

Ownership (MCTA)

Insider Ownership+68.19%
Institutional Ownership+0.27%
Shares Outstanding15.18M
Float5.46M
Short % of Float+11.90%

Source: Nexqual, October 16, 2026 at 05:58 UTC.

Leadership (MCTA)

Charming Medical Limited is led by Kit Wong (age 32), CEO & Chairman, per Nexqual as of October 16, 2026 at 05:58 UTC.

CEO & ChairmanKit Wong (age 32)
Chief Financial OfficerChing Man Cheung (age 43)

Major Backers & Investors (MCTA)

Notable institutional backers of Charming Medical Limited include UBS Group AG, according to Nexqual as of October 16, 2026 at 05:58 UTC.

Active Investors

InvestorStake
UBS Group AG0.16%

Source: Nexqual, October 16, 2026 at 05:58 UTC.

Peers & Related Stocks

SymbolNamePriceChange
INNVInnovAge Holding Corp.USD 8.98▼ 0.44%
USPHU.S. Physical Therapy, Inc.USD 85.98▲ 0.63%
NUTXNutex Health Inc.USD 200.8▼ 1.74%
HCSGHealthcare Services Group, Inc.USD 21.43▲ 2.58%
PNTGThe Pennant Group, Inc.USD 42.27▲ 5.28%
AGLagilon health, inc.USD 88.45▲ 2.97%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:58 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt